| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Oct―08 |
COVID-19 Vaccines Linked to Improved Survival in ICI-Treated Cancers |
|
| 2 |
[GO] |
2022―May―02 |
Top COVID-19 Prognostic Factors Identified |
|
| 3 |
[GO] |
2022―Apr―04 |
Vive la Résistance: T-cell Immunity in the Protection against SARS-CoV-2 Infection |
Lisa H.F. McGary, Santosha A. Vardhana |
| 4 |
[GO] |
2022―Mar―09 |
The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals. |
Jean-Eudes Fahrner, Imran Lahmar, Anne-Gaelle Goubet, Yacine Haddad, Agathe Carrier, Marine Mazzenga, et al. (+62) Damien Drubay, Carolina Alves Costa Silva, Lyon Covid Study Group, Eric de Sousa, Cassandra Thelemaque, Clea Melenotte, Agathe Dubuisson, Arthur Geraud, Gladys Ferrere, Roxanne Birebent, Camille Bigenwald, Marion Picard, Luigi Cerbone, Joana R. Lerias, Ariane Laparra, Alice Bernard-Tessier, Benoit Kloeckner, Marianne Gazzano, Francois-Xavier Danlos, Safae Terrisse, Eugenie Pizzato, Caroline Flament, Pierre Ly, Eric Tartour, Nadine Benhamouda, Lydia Meziani, Abdelhakim Ahmed-Belkacem, Makoto Miyara, Guy Gorochov, Fabrice Barlesi, Alexandre Trubert, Benjamin Ungar, Yeriel Estrada, Caroline Pradon, Emmanuelle Gallois, Fanny Pommeret, Emeline Colomba, Pernelle Lavaud, Marc Deloger, Nathalie Droin, Eric Deutsch, Bertrand Gachot, Jean-Philippe Spano, Mansouria Merad, Florian Scotte, Aurelien Marabelle, Frank Griscelli, Jean-Yves Blay, Jean-Charles Soria, Miriam Merad, Fabrice Andre, Juliette Villemonteix, Mathieu F. Chevalier, Sophie Caillat-Zucman, Florence Fenollar, Emma Guttman-Yassky, Odile Launay, Guido Kroemer, Bernard La Scola, Markus Maeurer, Lisa Derosa, Laurence Zitvogel |
| 5 |
[GO] |
2021―Dec―22 |
Pandemic Provides Rapid Test of Telehealth |
|
| 6 |
[GO] |
2021―Dec―10 |
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer |
Arielle Elkrief, Julie T Wu, Chinmay Jani, Kyle T Enriquez, Michael Glover, Mansi R Shah, et al. (+13) Hira Ghazal Shaikh, Alicia Beeghly-Fadiel, Benjamin French, Sachin R Jhawar, Douglas B. Johnson, Rana R McKay, Donna R Rivera, Daniel Y Reuben, Surbhi Shah, Stacey L Tinianov, Donald Cuong Vinh, Sanjay Mishra, Jeremy L Warner |
| 7 |
[GO] |
2021―Dec―09 |
Navigating Cancer Care in the COVID-19 Era |
|
| 8 |
[GO] |
2021―Nov―09 |
Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies |
Christina Y. Lee, Monika K Shah, David Hoyos, Alexander Solovyov, Melanie Douglas, Ying Taur, et al. (+5) Peter Maslak, N Esther Babady, Benjamin Greenbaum, Mini Kamboj, Santosha A Vardhana |
| 9 |
[GO] |
2021―Oct―06 |
COVID-19 Use Causes Tocilizumab Shortage |
|
| 10 |
[GO] |
2021―Sep―01 |
Impaired CD4 T-cell Response to SARS-CoV-2: Rationale for PD-1 Blockade in Patients with Cancer and COVID-19? |
Bérengère Salomé, Amir Horowitz |
| 11 |
[GO] |
2021―Jul―21 |
Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective |
Keith T. Flaherty, James H. Doroshow, Susan Galbraith, Antoni Ribas, Paul G. Kluetz, Richard Pazdur, Marc R. Theoret |
| 12 |
[GO] |
2021―Jul―16 |
Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine |
|
| 13 |
[GO] |
2021―Jul―07 |
COVID-19 Vaccines Complicate Breast Screening |
|
| 14 |
[GO] |
2021―Jun―04 |
COVID-19 Reshapes Cancer Clinical Research |
|
| 15 |
[GO] |
2021―May―19 |
Preexisting and post-COVID-19 immune responses to SARS-CoV-2 in cancer patients |
Tatjana Bilich, Malte Roerden, Yacine Maringer, Annika Nelde, Jonas S Heitmann, Marissa L Dubbelaar, et al. (+16) Andreas Peter, Sebastian Horber, Jens Bauer, Jonas Rieth, Marcel Wacker, Fiamma Berner, Lukas Flatz, Stefanie Held, Peter Brossart, Melanie Marklin, Philipp Wagner, Eva Erne, Reinhild Klein, Hans-Georg Rammensee, Helmut R Salih, Juliane S. Walz |
| 16 |
[GO] |
2021―May―14 |
Blood Cancers Diminish Response to COVID-19 Vaccine |
|
| 17 |
[GO] |
2021―Apr―12 |
Repurposing of anticancer drugs expands possibilities for antiviral and anti-inflammatory discovery in COVID-19 |
Mihaela Aldea, Jean-Marie Michot, Francois-Xavier Danlos, Antoni Ribas, Jean-Charles Soria |
| 18 |
[GO] |
2021―Apr―02 |
Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic |
Chris Labaki, Solange Peters, Toni K. Choueiri |
| 19 |
[GO] |
2021―Feb―26 |
COVID-19 Prolonged in Patients with Cancer |
|
| 20 |
[GO] |
2021―Feb―02 |
Correction: Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers |
|
| 21 |
[GO] |
2020―Dec―30 |
Patients with Cancer Seroconvert Typically After SARS-CoV-2 Infection |
|
| 22 |
[GO] |
2020―Dec―22 |
Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited |
Antoni Ribas, Rajarshi Sengupta, Trevan Locke, Sayyed Kaleem Zaidi, Katie M Campbell, John M. Carethers, et al. (+4) Elizabeth M. Jaffee, E. John Wherry, Jean-Charles Soria, Gypsyamber D'Souza |
| 23 |
[GO] |
2020―Dec―22 |
As Pandemic Continues, Screening Concerns Grow |
|
| 24 |
[GO] |
2020―Dec―11 |
Survival Factors ID'd for Patients with Blood Cancer + COVID-19 |
|
| 25 |
[GO] |
2020―Sep―18 |
Repurposing Cancer Drugs for COVID-19 |
|
| 26 |
[GO] |
2020―Sep―16 |
Q&A: Solange Peters on COVID-19, Cancer Intersection; Immunotherapy Biomarkers |
|
| 27 |
[GO] |
2020―Sep―01 |
COVID-19 Challenges Status Quo for Cancer Care |
|
| 28 |
[GO] |
2020―Aug―19 |
ICI Impact on COVID-19 Severity Modest at Best |
|
| 29 |
[GO] |
2020―Jul―31 |
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. |
David J Pinato, Alberto Zambelli, Juan Aguilar-Company, Mark Bower, Christopher CT Sng, Ramon Salazar, et al. (+58) Alexia Bertuzzi, Joan Brunet, Ricard Mesía, Elia Seguì, Federica Biello, Daniele Generali, Salvatore Grisanti, Gianpiero Rizzo, Michela Libertini, Antonio Maconi, Nadia Harbeck, Bruno Vincenzi, Rossella Bertulli, Diego Ottaviani, Anna Carbó, Riccardo Bruna, Sarah Benafif, Andrea Marrari, Rachel Wuerstlein, Maria Carmen Carmona-Garcia, Neha Chopra, Carlo Alberto Tondini, Oriol Mirallas, Valeria Tovazzi, Marta Betti, Salvatore Provenzano, Vittoria Fotia, Claudia Andrea Cruz, Alessia Dalla Pria, Francesca D'Avanzo, Joanne S Evans, Nadia Saoudi-Gonzalez, Eudald Felip, Myria Galazi, Isabel Garcia-Fructuoso, Alvin J X Lee, Thomas Newsom-Davis, Andrea Patriarca, David García-Illescas, Roxana Reyes, Palma Dileo, Rachel Sharkey, Yien Ning Sophia Wong, Daniela Ferrante, Javier Marco-Hernández, Anna Sureda, Clara Maluquer, Isabel Ruiz-Camps, Gianluca Gaidano, Lorenza Rimassa, Lorenzo Chiudinelli, Macarena Izuzquiza, Alba Cabirta, Michela Franchi, Armando Santoro, Aleix Prat, Josep Tabernero, Alessandra Gennari |
| 30 |
[GO] |
2020―Jul―22 |
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study |
Donna R Rivera, Solange Peters, Orestis A Panagiotou, Dimpy P Shah, Nicole M. Kuderer, Chih-Yuan Hsu, et al. (+39) Samuel M. Rubinstein, Brendan J Lee, Toni K Choueiri, Gilberto de Lima Lopes, Petros Grivas, Corrie A Painter, Brian I. Rini, Michael A. Thompson, Jonathan Arcobello, Ziad Bakouny, Deborah B Doroshow, Pamela C. Egan, Dimitrios Farmakiotis, Leslie Anne Fecher, Christopher R Friese, Matthew D Galsky, Sanjay Goel, Shilpa Gupta, Thorvardur R. Halfdanarson, Balazs Halmos, Jessica E Hawley, Ali Raza Khaki, Christopher A. Lemmon, Sanjay Mishra, Adam J Olszewski, Nathan A Pennell, Matthew M. Puc, Sanjay G. Revankar, Lidia Schapira, Andrew Schmidt, Gary K. Schwartz, Sumit A Shah, Julie T Wu, Zhuoer Xie, Albert C. Yeh, Huili Zhu, Yu Shyr, Gary H. Lyman, Jeremy L Warner |
| 31 |
[GO] |
2020―Jul―15 |
Cancer Research: The lessons to learn from COVID-19 |
Chris Bailey, James R M Black, Charles Swanton |
| 32 |
[GO] |
2020―Jun―08 |
COVID-19 Delays Cancer Screenings |
|
| 33 |
[GO] |
2020―May―29 |
Registries Offer Insights on COVID-19-Cancer Connection |
|
| 34 |
[GO] |
2020―May―22 |
The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2 |
Beril Tutuncuoglu, Merve Cakir, Jyoti Batra, Mehdi Bouhaddou, Manon Eckhardt, David E Gordon, Nevan J Krogan |
| 35 |
[GO] |
2020―May―13 |
The Era of COVID-19 and the Rise of Science Collectivism in Cancer Research |
Tobias Janowitz, David A. Tuveson |
| 36 |
[GO] |
2020―May―12 |
Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers |
Jia Luo, Hira Rizvi, Jacklynn V Egger, Isabel R Preeshagul, Jedd D. Wolchok, Matthew D. Hellmann |
| 37 |
[GO] |
2020―May―05 |
Cytokine Storm Drugs Move from CAR T to COVID-19 |
|
| 38 |
[GO] |
2020―May―01 |
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System |
Vikas Mehta, Sanjay Goel, Rafi Kabarriti, Daniel Cole, Mendel Goldfinger, Ana Acuna-Villaorduna, et al. (+13) Kith Pradhan, Raja Thota, Stan Reissman, Joseph A. Sparano, Benjamin A Gartrell, Richard V. Smith, Nitin Ohri, Madhur Garg, Andrew D. Racine, Shalom Kalnicki, Roman Perez-Soler, Balazs Halmos, Amit Verma |
| 39 |
[GO] |
2020―Apr―28 |
Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak |
Mengyuan Dai, Dianbo Liu, Miao Liu, Fuxiang Zhou, Guiling Li, Zhen Chen, et al. (+32) Zhian Zhang, Hua You, Meng Wu, Qichao Zheng, Yong Xiong, Huihua Xiong, Chun Wang, Changchun Chen, Fei Xiong, Yan Zhang, Yaqin Peng, Siping Ge, Bo Zhen, Tingting Yu, Ling Wang, Hua Wang, Yu Liu, Yeshan Chen, Junhua Mei, Xiaojia Gao, Zhuyan Li, Lijuan Gan, Can He, Zhen Li, Yuying Shi, Yuwen Qi, Jing Yang, Daniel G Tenen, Li Chai, Lorelei A. Mucci, Mauricio Santillana, Hongbing Cai |
| 40 |
[GO] |
2020―Apr―24 |
COVID-19 Hits Cancer Research Funding |
|
| 41 |
[GO] |
2020―Apr―20 |
COVID-19 More Frequent, Severe in Cancer Patients |
|
| 42 |
[GO] |
2020―Apr―17 |
Harnessing CAR T Cell Insights to Develop Treatments for Hyperinflammatory Responses in COVID-19 patients |
Sangya Agarwal, Carl H. June |
| 43 |
[GO] |
2020―Apr―15 |
AACR Calls on Congress to Take Immediate Action Against COVID-19 and Protect Patients with Cancer During the Pandemic |
|
| 44 |
[GO] |
2020―Apr―10 |
Cancer Care Goes Virtual in Response to COVID-19 |
|
| 45 |
[GO] |
2020―Apr―10 |
TMPRSS2 and COVID-19: Serendipity or opportunity for intervention? |
Konrad H. Stopsack, Lorelei A. Mucci, Emmanuel S. Antonarakis, Peter S. Nelson, Philip W. Kantoff |
| 46 |
[GO] |
2020―Apr―01 |
Clinical Research Slows as COVID-19 Surges |
|
| 47 |
[GO] |
2020―Mar―31 |
Cancer Labs Pivot to Battle COVID-19 |
|
| 48 |
[GO] |
2020―Mar―24 |
COVID-19 Challenges Basic Researchers |
|
|
